Genome Analysis of Anti-Phage Defense Systems and Defense Islands in Stenotrophomonas maltophilia: Preservation and Variability
- PMID: 39772210
- PMCID: PMC11680222
- DOI: 10.3390/v16121903
Genome Analysis of Anti-Phage Defense Systems and Defense Islands in Stenotrophomonas maltophilia: Preservation and Variability
Abstract
Anti-phage defense systems are widespread in bacteria due to the latter continuous adaptation to infection by bacteriophages (phages). Stenotrophomonas maltophilia has a high degree of intrinsic antibiotic resistance, which makes phage therapy relevant for the treatment of infections caused by this species. Studying the array of anti-phage defense systems that could be found in S. maltophilia helps in better adapting the phages to the systems present in the pathogenic bacteria. Pangenome analysis of the available S. maltophilia strains with complete genomes that were downloaded from GenBank, including five local genomes, indicated a wide set of 72 defense systems and subsystems that varied between the strains. Seven of these systems were present in more than 20% of the studied genomes and the proteins encoded by the systems were variable in most of the cases. A total of 27 defense islands were revealed where defense systems were found; however, more than 60% of the instances of systems were found in four defense islands. Several elements linked to the transfer of these systems were found. No obvious associations between the pattern of distribution of the anti-phage defense systems of S. maltophilia and the phylogenetic features or the isolation site were found.
Keywords: S. maltophilia; anti-phage defense systems; defense islands; phage therapy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures









Similar articles
-
Genomic insights into the phage-defense systems of Stenotrophomonas maltophilia clinical isolates.Microbiol Res. 2024 Jan;278:127528. doi: 10.1016/j.micres.2023.127528. Epub 2023 Oct 17. Microbiol Res. 2024. PMID: 37918082
-
The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia.Viruses. 2021 Jun 3;13(6):1057. doi: 10.3390/v13061057. Viruses. 2021. PMID: 34204897 Free PMC article. Review.
-
Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling.Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0116224. doi: 10.1128/aac.01162-24. Epub 2025 Jan 22. Antimicrob Agents Chemother. 2025. PMID: 39840957 Free PMC article.
-
Characterization of phage evolution and phage resistance in drug-resistant Stenotrophomonas maltophilia.J Virol. 2024 Feb 20;98(2):e0124923. doi: 10.1128/jvi.01249-23. Epub 2024 Jan 8. J Virol. 2024. PMID: 38189285 Free PMC article.
-
The versatility and adaptation of bacteria from the genus Stenotrophomonas.Nat Rev Microbiol. 2009 Jul;7(7):514-25. doi: 10.1038/nrmicro2163. Nat Rev Microbiol. 2009. PMID: 19528958 Review.
Cited by
-
Structural Insights into the Regulatory Mechanisms of the Toxic Activity of Sofic in Anti-Phage Defense Systems.Int J Mol Sci. 2025 Jun 24;26(13):6074. doi: 10.3390/ijms26136074. Int J Mol Sci. 2025. PMID: 40649851 Free PMC article.
-
Optimizing bacteriophage screening and isolation methods for microbial samples derived from different body sites of cattle.bioRxiv [Preprint]. 2025 Jul 5:2025.07.04.663187. doi: 10.1101/2025.07.04.663187. bioRxiv. 2025. PMID: 40631329 Free PMC article. Preprint.
References
-
- Pompilio A., Crocetta V., Confalone P., Nicoletti M., Petrucca A., Guarnieri S., Fiscarelli E., Savini V., Piccolomini R., Di Bonaventura G. Adhesion to and Biofilm Formation on IB3-1 Bronchial Cells by Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients. BMC Microbiol. 2010;10:102. doi: 10.1186/1471-2180-10-102. - DOI - PMC - PubMed
-
- Fluit A.C., Bayjanov J.R., Aguilar M.D., Cantón R., Elborn S., Tunney M.M., Scharringa J., Benaissa-Trouw B.J., Ekkelenkamp M.B. Taxonomic Position, Antibiotic Resistance and Virulence Factor Production by Stenotrophomonas Isolates from Patients with Cystic Fibrosis and Other Chronic Respiratory Infections. BMC Microbiol. 2022;22:129. doi: 10.1186/s12866-022-02466-5. - DOI - PMC - PubMed
-
- WHO|World Health Organization. [(accessed on 7 March 2021)]. Available online: https://www.who.int/health-topics/antimicrobial-resistance.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources